All Stories

  1. Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8

    Article • Cancers, July 2023, MDPI AG

    FRANCESC SOLE

  2. Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

    Article • Journal of Clinical Oncology, May 2023, American Society of Clinical Oncology (ASCO)

    FRANCESC SOLE

  3. Supplementary Data from Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in <i>SF3B1</i>-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts

    Article • April 2023, American Association for Cancer Research (AACR)

    FRANCESC SOLE

  4. European standard clinical practice – Key issues for the medical care of individuals with familial leukemia

    Article • European Journal of Medical Genetics, April 2023, Elsevier

    FRANCESC SOLE

  5. The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw

    Article • Cancers, February 2023, MDPI AG

    FRANCESC SOLE

  6. A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study

    Article • The Lancet Haematology, February 2023, Elsevier

    FRANCESC SOLE

  7. Mutational Profile Enables the Identification of a High Risk Subgroup in Myelodysplastic Syndromes With Isolated Trisomy 8

    Article • February 2023, Research Square

    FRANCESC SOLE

  8. Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?

    Article • British Journal of Haematology, January 2023, Wiley

    FRANCESC SOLE

  9. MUTATIONAL PROFILE ENABLES THE IDENTIFICATION OF A HIGH RISK SUBGROUP IN MYELODYSPLASTIC SYNDROMES WITH ISOLATED TRISOMY 8

    Article • January 2023, Cold Spring Harbor Laboratory Press

    FRANCESC SOLE

  10. 3032 – SIMULTANEOUS SINGLE-CELL DNA METHYLATION AND TRANSCRIPTOMIC ANALYSIS DISCLOSE CLONAL PHYLO-EPIGENETIC EVOLUTION IN MYELODYSPLASTIC SYNDROME

    Article • Experimental Hematology, January 2023, Elsevier

    FRANCESC SOLE

  11. Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  12. Bone Marrow WT1 mRNA Upregulation in Acute Myeloid Leukemia (AML) in Complete Molecular Remission (mCR): Understanding the Limitations and Advantages of WT1 As a Measurable Residual Disease (MRD) Target

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  13. Characterization of Transcriptional Alterations Leading to Aberrant Myeloid Differentiation in Myelodysplastic Syndromes

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  14. Clinical Implications of p53 Dysfunction in Patients with Myelodysplastic Syndromes

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  15. ERCC6L2 in Early-Onset Adult Myelodysplastic Syndrome without Pre-Existing Disorder

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  16. Incidence, Clinical Associations, and Co-Mutation Patterns of UBA1 Mutations in MDS

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  17. Pilot Inter-Laboratory Comparison Study of Optical Genome Mapping Analysis for Cytogenomic Characterization of Hematological Malignancies: A Spanish Multicentric Study

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  18. Real-World Validation of Molecular International Prognostic Scoring System (IPSS-M) for Myelodysplastic Syndromes

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  19. Subclonal KIT D816V Mutations Are Prevalent in Chronic Myelomonocytic Leukemia and Correlate with Distinct Phenotypic Features

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  20. TP53 Allelic State in Myelodysplastic Syndromes with 5q Deletion

    Article • Blood, November 2022, American Society of Hematology

    FRANCESC SOLE

  21. Myelodysplastic Syndromes with Isolated del(5q): Value of Molecular Alterations for Diagnostic and Prognostic Assessment

    Article • Cancers, November 2022, MDPI AG

    FRANCESC SOLE

  22. Targeting the EIF2AK1 Signaling Pathway Rescues Red Blood Cell Production in SF3B1-Mutant Myelodysplastic Syndromes With Ringed Sideroblasts

    Article • Blood Cancer Discovery, August 2022, American Association for Cancer Research (AACR)

    FRANCESC SOLE

  23. CD34+CD19−CD22+ B-cell progenitors may underlie phenotypic escape in patients treated with CD19-directed therapies

    Article • Blood, July 2022, American Society of Hematology

    FRANCESC SOLE

  24. Pathophysiologic and clinical implications of molecular profiles resultant from deletion 5q

    Article • EBioMedicine, June 2022, Elsevier

    FRANCESC SOLE

  25. Guiding the global evolution of cytogenetic testing for hematologic malignancies

    Article • Blood, April 2022, American Society of Hematology

    FRANCESC SOLE

  26. Clinical relevance of clonal hematopoiesis in persons aged ≥80 years

    Article • Blood, November 2021, American Society of Hematology

    FRANCESC SOLE

  27. Deficiency of RPS14 Beyond the Haploinsufficient Loss in Del(5q)

    Article • Blood, November 2021, American Society of Hematology

    FRANCESC SOLE

  28. Germline and Somatic Variants Co-Ocurrence Profile in Early Onset Adult Myelodysplastic Syndromes without a Preexisting Disorder

    Article • Blood, November 2021, American Society of Hematology

    FRANCESC SOLE

  29. Prevalencia y características de la hematopoyesis clonal en insuficiencia cardiaca

    Article • Revista Española de Cardiología, November 2021, Elsevier

    FRANCESC SOLE

  30. Divergent leukaemia subclones as cellular models for testing vulnerabilities associated with gains in chromosomes 7, 8 or 18

    Article • Scientific Reports, October 2021, Springer Science + Business Media

    FRANCESC SOLE

  31. Adverse prognostic impact of complex karyotype (≥3 cytogenetic alterations) in adult T-cell acute lymphoblastic leukemia (T-ALL)

    Article • Leukemia Research, October 2021, Elsevier

    FRANCESC SOLE

  32. Beyond morphology: to be or not to be an MDS

    Article • British Journal of Haematology, June 2021, Wiley

    FRANCESC SOLE

  33. Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Article • Nature Medicine, May 2021, Springer Science + Business Media

    FRANCESC SOLE

  34. Genetic Aspects of Myelodysplastic/Myeloproliferative Neoplasms

    Article • Cancers, April 2021, MDPI AG

    FRANCESC SOLE

  35. A Single-Run Next-Generation Sequencing (NGS) Assay for the Simultaneous Detection of Both Gene Mutations and Large Chromosomal Abnormalities in Patients with Myelodysplastic Syndromes (MDS) and Related Myeloid Neoplasms

    Article • Cancers, April 2021, MDPI AG

    FRANCESC SOLE

  36. Classification and Personalized Prognostic Assessment on the Basis of Clinical and Genomic Features in Myelodysplastic Syndromes

    Article • Journal of Clinical Oncology, April 2021, American Society of Clinical Oncology (ASCO)

    FRANCESC SOLE

  37. Analysis of Intratumoral Heterogeneity in Myelodysplastic Syndromes with Isolated del(5q) Using a Single Cell Approach

    Article • Cancers, February 2021, MDPI AG

    FRANCESC SOLE

  38. Author Correction: Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Article • Nature Medicine, February 2021, Springer Science + Business Media

    FRANCESC SOLE

  39. Genetic characterization of acute myeloid leukemia patients with mutations in IDH1/2 genes

    Article • Leukemia Research, February 2021, Elsevier

    FRANCESC SOLE

  40. Aneuploidy in Cancer: Lessons from Acute Lymphoblastic Leukemia

    Article • Trends in Cancer, January 2021, Elsevier

    FRANCESC SOLE

  41. Analysis of distinct SF3B1 hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia

    Article • Leukemia & Lymphoma, November 2020, Taylor & Francis

    FRANCESC SOLE

  42. Molecular landscape and clonal architecture of adult myelodysplastic/myeloproliferative neoplasms

    Article • Blood, October 2020, American Society of Hematology

    FRANCESC SOLE

  43. Cytogenetics in the genomic era

    Article • Best Practice & Research Clinical Haematology, September 2020, Elsevier

    FRANCESC SOLE

  44. ALL-257: Unraveling IKZF1 Deletion Therapeutic Vulnerabilities in Adult B-Cell Precursor Acute Lymphoblastic Leukemia

    Article • Clinical Lymphoma Myeloma & Leukemia, September 2020, Elsevier

    FRANCESC SOLE

  45. Implications of TP53 allelic state for genome stability, clinical presentation and outcomes in myelodysplastic syndromes

    Article • Nature Medicine, August 2020, Springer Science + Business Media

    FRANCESC SOLE

  46. SF3B1: the lord of the rings in MDS

    Article • Blood, July 2020, American Society of Hematology

    FRANCESC SOLE

  47. Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS

    Article • Leukemia, June 2020, Springer Science + Business Media

    FRANCESC SOLE

  48. Impact of somatic mutations in myelodysplastic patients with isolated partial or total loss of chromosome 7

    Article • Leukemia, February 2020, Springer Science + Business Media

    FRANCESC SOLE

  49. Rare germline variant contributions to myeloid malignancy susceptibility

    Article • Leukemia, January 2020, Springer Science + Business Media

    FRANCESC SOLE

  50. Non-del(5q) myelodysplastic syndromes–associated loci detected by SNP-array genome-wide association meta-analysis

    Article • Blood Advances, November 2019, American Society of Hematology

    FRANCESC SOLE

  51. Can Monosomy 7 be Targeted By Next Generation Cereblon-Modulating Agents?

    Article • Blood, November 2019, American Society of Hematology

    FRANCESC SOLE

  52. Germinal Predisposition in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction: Identification of Deleterious Variants in Microsatellite Instability Genes

    Article • Blood, November 2019, American Society of Hematology

    FRANCESC SOLE

  53. Hotspot U2AF1 Mutations Determine Missplicing Selectivity: Novel Mechanisms Altering Splicing Factors

    Article • Blood, November 2019, American Society of Hematology

    FRANCESC SOLE

  54. Integrated Transcriptomic and Proteomic Analyses of Inflammasome in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

    Article • Blood, November 2019, American Society of Hematology

    FRANCESC SOLE

  55. MPO as a Novel Susceptibility Gene in Myeloid Malignancies

    Article • Blood, November 2019, American Society of Hematology

    FRANCESC SOLE

  56. Molecular Dissection of Del(5q): Distinction between Primary and Secondary Del(5q) and Pathogenetic Implications

    Article • Blood, November 2019, American Society of Hematology

    FRANCESC SOLE

  57. TP53 State Dictates Genome Stability, Clinical Presentation and Outcomes in Myelodysplastic Syndromes

    Article • Blood, November 2019, American Society of Hematology

    FRANCESC SOLE

  58. TP53 Status As Well As Cytogenetic Complexity Significantly Impact on Prognosis in Myelodysplastic Syndromes with Complex (≥3 anomalies) Aberrant Karyotypes

    Article • Blood, November 2019, American Society of Hematology

    FRANCESC SOLE

  59. Spanish Guidelines for the use of targeted deep sequencing in myelodysplastic syndromes and chronic myelomonocytic leukaemia

    Article • British Journal of Haematology, October 2019, Wiley

    FRANCESC SOLE

  60. Report of the SMZL meeting in Badalona, Barcelona, Spain

    Article • Leukemia & Lymphoma, October 2019, Taylor & Francis

    Dr Estella Matutes, FRANCESC SOLE

  61. Molecular profiling refines minimal residual disease‐based prognostic assessment in adults with Philadelphia chromosome‐negative B‐cell precursor acute lymphoblastic leukemia

    Article • Genes Chromosomes and Cancer, August 2019, Wiley

    FRANCESC SOLE

  62. Diagnostic and prognostic contribution of targeted NGS in patients with triple‐negative myeloproliferative neoplasms

    Article • American Journal of Hematology, August 2019, Wiley

    FRANCESC SOLE

  63. Comprehensive analysis of isolated der(1;7)(q10;p10) in a large international homogenous cohort of patients with myelodysplastic syndromes

    Article • Genes Chromosomes and Cancer, April 2019, Wiley

    FRANCESC SOLE

  64. The poor prognosis of low hypodiploidy in adults with B‐cell precursor acute lymphoblastic leukaemia is restricted to older adults and elderly patients

    Article • British Journal of Haematology, March 2019, Wiley

    FRANCESC SOLE

  65. Opposing Pathogenesis of Germline SAMD9/SAMD9L Variants in Adult Myelodysplastic Syndrome (MDS)

    Article • Blood, November 2018, American Society of Hematology

    FRANCESC SOLE

  66. Germline and Acquired Genetic Variants in Myelodysplastic Syndromes in Young Adults without a Preexisting Disorder or Organ Dysfunction

    Article • Blood, November 2018, American Society of Hematology

    FRANCESC SOLE

  67. Molecular Spectrum of CSF3R variants Correlate with Specific Myeloid Malignancies and Secondary Mutations

    Article • Blood, November 2018, American Society of Hematology

    FRANCESC SOLE

  68. SNP-Array Genome Wide Association Study Meta-Analysis Identifies Innate Immune Susceptibility Loci Associated with Non-Del(5q) Myelodysplastic Syndromes Predisposition

    Article • Blood, November 2018, American Society of Hematology

    FRANCESC SOLE

  69. Therapy-Related MDS Can be Separated into Different Risk-Groups According to Tools for Classification and Prognostication of Primary MDS

    Article • Blood, November 2018, American Society of Hematology

    FRANCESC SOLE

  70. Germline loss-of-function SAMD9 and SAMD9L alterations in adult myelodysplastic syndromes

    Article • Blood, November 2018, American Society of Hematology

    FRANCESC SOLE

  71. Translational Research Opportunities Regarding Homologous Recombination in Ovarian Cancer

    Article • International Journal of Molecular Sciences, October 2018, MDPI AG

    FRANCESC SOLE

  72. Differing clinical features between Japanese and Caucasian patients with myelodysplastic syndromes: Analysis from the International Working Group for Prognosis of MDS

    Article • Leukemia Research, October 2018, Elsevier

    FRANCESC SOLE

  73. Clonal architecture in patients with myelodysplastic syndromes and double or minor complex abnormalities: Detailed analysis of clonal composition, involved abnormalities, and prognostic significance

    Article • Genes Chromosomes and Cancer, September 2018, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  74. Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML

    Article • Scientific Reports, September 2018, Springer Science + Business Media

    FRANCESC SOLE

  75. Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia

    Article • Journal of Hematology & Oncology, July 2018, Springer Science + Business Media

    FRANCESC SOLE

  76. Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia

    Article • British Journal of Haematology, May 2018, Wiley

    FRANCESC SOLE

  77. Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes

    Article • American Journal of Hematology, April 2018, Wiley

    FRANCESC SOLE

  78. Clinical and biological significance of isolated Y chromosome loss in myelodysplastic syndromes and chronic myelomonocytic leukemia. A report from the Spanish MDS Group

    Article • Leukemia Research, December 2017, Elsevier

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  79. DNA methylation profile in chronic myelomonocytic leukemia associates with distinct clinical, biological and genetic features

    Article • Epigenetics, November 2017, Taylor & Francis

    FRANCESC SOLE

  80. Copy number profiling of adult relapsed B-cell precursor acute lymphoblastic leukemia reveals potential leukemia progression mechanisms

    Article • Genes Chromosomes and Cancer, August 2017, Wiley

    Professor Josep-Maria Ribera, FRANCESC SOLE

  81. Inspecting Targeted Deep Sequencing of Whole Genome Amplified DNA Versus Fresh DNA for Somatic Mutation Detection: A Genetic Study in Myelodysplastic Syndrome Patients

    Article • Biopreservation and Biobanking, August 2017, Mary Ann Liebert Inc

    FRANCESC SOLE

  82. Monosomal karyotype in chronic lymphocytic leukemia: Association with clinical and biological features and potential prognostic significance

    Article • American Journal of Hematology, June 2017, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  83. A Single Next-Generation Sequencing (NGS) Assay for the Detection of Point Mutations and Large Chromosomal Abnormalities in MDS Patients

    Article • Leukemia Research, April 2017, Elsevier

    FRANCESC SOLE

  84. Ancestral Events Including Germline and Somatic Mutations Determine Subclonal Events and Affect Phenotype of Progression in MDS

    Article • Leukemia Research, April 2017, Elsevier

    FRANCESC SOLE

  85. Chromosomal Aberrations in Therapy-Related Myelodysplastic Syndromes – Relations to Primary Disease, Therapy and Prognostic Significance

    Article • Leukemia Research, April 2017, Elsevier

    FRANCESC SOLE

  86. DNA Methylation Profiling in Patients with CMML Differs Between Normal and Altered Karyotype

    Article • Leukemia Research, April 2017, Elsevier

    FRANCESC SOLE

  87. DNA Repair Genes Transcriptome in Chronic Myelomonocytic Leukemia

    Article • Leukemia Research, April 2017, Elsevier

    FRANCESC SOLE

  88. Mutational Signature and Clonal Architecture of Low Risk Myelodysplastic Syndromes with Del(5Q)

    Article • Leukemia Research, April 2017, Elsevier

    FRANCESC SOLE

  89. Spanish Guidelines for the use of Targeted Deep Sequencing in MDS and CMML

    Article • Leukemia Research, April 2017, Elsevier

    FRANCESC SOLE

  90. Targeted Deep Sequencing of Peripheral CD34+ Cells can Reproduce Bone Marrow Molecular Profile in MDS Patients

    Article • Leukemia Research, April 2017, Elsevier

    FRANCESC SOLE

  91. Computational drug treatment simulations on projections of dysregulated protein networks derived from the myelodysplastic mutanome match clinical response in patients

    Article • Leukemia Research, January 2017, Elsevier

    FRANCESC SOLE

  92. In MDS Targeted Deep Sequencing of CD34+ Blood Cells but Not Peripheral Blood Mononuclear Cells Give Results Which Are Representative for Bone Marrow

    Article • Blood, December 2016, American Society of Hematology

    FRANCESC SOLE

  93. Application of Trusight Myeloid Panel on Whole Genome Amplified DNA in Myelodysplastic Syndrome Patients

    Article • Blood, December 2016, American Society of Hematology

    FRANCESC SOLE

  94. Comparison of the Molecular Spectrum of Lenalidomide-Treated Myelodysplastic Syndrome with and without Del(5q)

    Article • Blood, December 2016, American Society of Hematology

    FRANCESC SOLE

  95. Frequency and Prognostic Significance of Cytogenetic Abnormalities in 1269 Patients with Therapy-Related Myelodysplastic Syndrome - a Study of the International Working Group (IWG-PM) for Myelodysplastic Syndromes (MDS)

    Article • Blood, December 2016, American Society of Hematology

    FRANCESC SOLE

  96. Genomic Characterization of Paired Diagnosis and Relapse Samples from Adult Patients with B-Cell Precursor Acute Lymphoblastic Leukemia

    Article • Blood, December 2016, American Society of Hematology

    FRANCESC SOLE

  97. Landscape of Subclonal Mutations in Myelodysplastic Syndromes (MDS) Allows for a Novel Hierarchy of Clonal Advantage By Combining Germline and Somatic Mutations

    Article • Blood, December 2016, American Society of Hematology

    FRANCESC SOLE

  98. Molecular and Clinical Characterization of Patients with Myeloid Neoplasms Carrying the 12p Deletion

    Article • Blood, December 2016, American Society of Hematology

    FRANCESC SOLE

  99. Immunophenotypic, cytogenetic, and mutational characterization of cell lines derived from myelodysplastic syndrome patients after progression to acute myeloid leukemia

    Article • Genes Chromosomes and Cancer, November 2016, Wiley

    FRANCESC SOLE

  100. Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

    Article • Blood, October 2016, American Society of Hematology

    FRANCESC SOLE

  101. Molecular predictors of response in patients with myeloid neoplasms treated with lenalidomide

    Article • Leukemia, August 2016, Springer Science + Business Media

    FRANCESC SOLE

  102. Time-dependent changes in mortality and transformation risk in MDS

    Article • Blood, August 2016, American Society of Hematology

    FRANCESC SOLE

  103. Targeted deep sequencing improves outcome stratification in chronic myelomonocytic leukemia with low risk cytogenetic features

    Article • Oncotarget, July 2016, Impact Journals, LLC

    FRANCESC SOLE

  104. Abstract 2570: Identification of genetic polymorphisms associated with myelodysplastic syndromes by genome-wide association study

    Article • Cancer Research, July 2016, American Association for Cancer Research (AACR)

    FRANCESC SOLE

  105. Feasibility of the AML profiler (Skyline™ Array) for patient risk stratification in a multicentre trial: a preliminary comparison with the conventional approach

    Article • Hematological Oncology, May 2016, Wiley

    Josep Nomdedeu, FRANCESC SOLE

  106. Prognostic impact of chromosomal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemia patients. A study by the spanish group of myelodysplastic syndromes

    Article • Genes Chromosomes and Cancer, December 2015, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  107. Impact of SNP array karyotyping on the diagnosis and the outcome of chronic myelomonocytic leukemia with low risk cytogenetic features or no metaphases

    Article • American Journal of Hematology, December 2015, Wiley

    FRANCESC SOLE

  108. Molecular Genetic Profiling in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features

    Article • Blood, December 2015, American Society of Hematology

    FRANCESC SOLE

  109. Downregulation of BAP1 in Chronic Myelomonocytic Leukemia: Correlated with a Post-Translational Reduction of BRCA1 Levels and Independent of Promoter Methylation

    Article • Blood, December 2015, American Society of Hematology

    FRANCESC SOLE

  110. Predicting MDS Response to Drug Therapies Based on a New Method of Interpreting the MDS Mutanome

    Article • Blood, December 2015, American Society of Hematology

    FRANCESC SOLE

  111. Prognostic Impact of Rare Single Abnormalities in Myelodysplastic Syndromes

    Article • Blood, December 2015, American Society of Hematology

    FRANCESC SOLE

  112. Refining the Breakpoints of Three New Translocations Identified in Myelodysplastic Syndromes

    Article • Acta Haematologica, October 2015, Karger Publishers

    FRANCESC SOLE

  113. TP53 and MDM2 single nucleotide polymorphisms influence survival in non-del(5q) myelodysplastic syndromes

    Article • Oncotarget, September 2015, Impact Journals, LLC

    FRANCESC SOLE

  114. Frequency of del(12p) is commonly underestimated in myelodysplastic syndromes: Results from a German diagnostic study in comparison with an international control group

    Article • Genes Chromosomes and Cancer, September 2015, Wiley

    FRANCESC SOLE

  115. TP53 and MDM2 single nucleotide polymorphisms influence survival in myelodysplastic syndromes

    Article • Clinical Lymphoma Myeloma & Leukemia, September 2015, Elsevier

    FRANCESC SOLE

  116. Prognostic significance of copy number alterations in adolescent and adult patients with precursor B acute lymphoblastic leukemia enrolled in PETHEMA protocols

    Article • Cancer, July 2015, Wiley

    Professor Josep-Maria Ribera, Josep Nomdedeu, FRANCESC SOLE

  117. Trisomy 8, a Cytogenetic Abnormality in Myelodysplastic Syndromes, Is Constitutional or Not?

    Article • PLoS ONE, June 2015, PLOS

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  118. Copy Number Alterations in patients with mature B (Burkitt-type) acute lymphoblastic leukaemia treated with specific immunochemotherapy

    Article • Clinical Lymphoma Myeloma & Leukemia, June 2015, Elsevier

    FRANCESC SOLE

  119. Fluorescencein situhybridization ofTP53for the detection of chromosome 17 abnormalities in myelodysplastic syndromes

    Article • Leukemia & Lymphoma, May 2015, Taylor & Francis

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  120. The relationship of TP53 R72P polymorphism to disease outcome and TP53 mutation in myelodysplastic syndromes

    Article • Blood Cancer Journal, March 2015, Springer Science + Business Media

    FRANCESC SOLE

  121. Validation of WHO classification-based Prognostic Scoring System (WPSS) for myelodysplastic syndromes and comparison with the revised International Prognostic Scoring System (IPSS-R). A study of the International Working Group for Prognosis in Myelodys...

    Article • Leukemia, February 2015, Springer Science + Business Media

    FRANCESC SOLE

  122. Correlation of myelodysplastic syndromes with i(17)(q10) andTP53andSETBP1mutations

    Article • British Journal of Haematology, February 2015, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  123. Acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2): Clinical and biological features and comparison with other acute myeloid leukemias with cytogenetic aberrations involving long arm of chromosome 3

    Article • Hematology, February 2015, Taylor & Francis

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  124. 20th International Chromosome Conference (ICCXX)

    Article • Chromosome Research, January 2015, Springer Science + Business Media

    Professor Karol Marhold, FRANCESC SOLE

  125. Genomic Microarray Alterations Add Prognostic Power to the IPSS-R in MDS with Normal Karyotype

    Article • Blood, December 2014, American Society of Hematology

    FRANCESC SOLE

  126. Whole-Exome Sequencing in Myelodysplastic Syndromes with 5q Deletion

    Article • Blood, December 2014, American Society of Hematology

    FRANCESC SOLE

  127. Genetic Markers Add Significant Prognostic Information to Age and WBC Count in High-Risk, Ph-Negative, B-Precursor Adult Acute Lymphoblastic Leukemia (ALL): Study of 96 Patients Treated According to Risk-Adapted Protocols from the Pethema Group

    Article • Blood, December 2014, American Society of Hematology

    FRANCESC SOLE

  128. Utility of SNP Arrays in Chronic Myelomonocytic Leukemia with Low Risk Cytogenetic Features or No Metaphases

    Article • Blood, December 2014, American Society of Hematology

    FRANCESC SOLE

  129. Validation of cytogenetic risk groups according to International Prognostic Scoring Systems by peripheral blood CD34+FISH: results from a German diagnostic study in comparison with an international control group

    Article • Haematologica, October 2014, Ferrata Storti Foundation (Haematologica)

    FRANCESC SOLE

  130. Combined analysis of copy number alterations by single-nucleotide polymorphism array and MYC status in non-metastatic breast cancer patients: comparison according to the circulating tumor cell status

    Article • Tumor Biology, October 2014, Springer Science + Business Media

    FRANCESC SOLE

  131. Role of Casein Kinase 1A1 in the Biology and Targeted Therapy of del(5q) MDS

    Article • Cancer Cell, October 2014, Elsevier

    FRANCESC SOLE

  132. TERT gene amplification is associated with poor outcome in acral lentiginous melanoma

    Article • Journal of the American Academy of Dermatology, October 2014, Elsevier

    FRANCESC SOLE

  133. Paraffin Treasures: Do They Last Forever?

    Article • Biopreservation and Biobanking, August 2014, Mary Ann Liebert Inc

    FRANCESC SOLE

  134. EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer

    Article • Oncotarget, July 2014, Impact Journals, LLC

    FRANCESC SOLE

  135. Guidance for laboratories performing molecular pathology for cancer patients

    Article • Journal of Clinical Pathology, July 2014, BMJ

    FRANCESC SOLE

  136. Fluorescencein situhybridization analysis does not increase detection rate for trisomy 8 in chronic myelomonocytic leukemia

    Article • Leukemia & Lymphoma, June 2014, Taylor & Francis

    FRANCESC SOLE

  137. Translocation t(2;7)(p11.2;q21.2): a rare genetic aberration associated with B-cell lymphoproliferative disorders of marginal-zone origin

    Article • Cancer Genetics, June 2014, Elsevier

    FRANCESC SOLE

  138. Errors in the interpretation of copy number variations due to the use of public databases as a reference

    Article • Cancer Genetics, April 2014, Elsevier

    FRANCESC SOLE

  139. Intervention to improve social and family support for caregivers of dependent patients: ICIAS study protocol

    Article • BMC Family Practice, March 2014, Springer Science + Business Media

    FRANCESC SOLE

  140. TERT and AURKA Gene Copy Number Gains Enhance the Detection of Acral Lentiginous Melanomas by Fluorescence in Situ Hybridization

    Article • Journal of Molecular Diagnostics, March 2014, Elsevier

    Susana Puig, FRANCESC SOLE

  141. Distinction between Asymptomatic Monoclonal B-cell Lymphocytosis with Cyclin D1 Overexpression and Mantle Cell Lymphoma: From Molecular Profiling to Flow Cytometry

    Article • Clinical Cancer Research, December 2013, American Association for Cancer Research (AACR)

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  142. Whole-exome sequencing in splenic marginal zone lymphoma reveals mutations in genes involved in marginal zone differentiation

    Article • Leukemia, December 2013, Springer Science + Business Media

    Dr Francesco Bertoni, FRANCESC SOLE

  143. Analysis Of Transfusion Dependence Development and Disease Evolution In Patients With MDS and Del(5q) and Without Transfusion Needs At Diagnosis

    Article • Blood, November 2013, American Society of Hematology

    FRANCESC SOLE

  144. Prognostic Significance Of Copy Number Alterations In B-Lineage Adult Acute Lymphoblastic Leukemia Patients Enrolled In Risk-Adapted Protocols From The Pethema Group

    Article • Blood, November 2013, American Society of Hematology

    FRANCESC SOLE

  145. Time Changes In Predictive Power Of MDS Prognostic Scores – Effects On Revised Scores Such As The IPSS-R, Impact Of Age

    Article • Blood, November 2013, American Society of Hematology

    FRANCESC SOLE

  146. Single nucleotide polymorphism array karyotyping: A diagnostic and prognostic tool in myelodysplastic syndromes with unsuccessful conventional cytogenetic testing

    Article • Genes Chromosomes and Cancer, October 2013, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  147. The pursuit of knowledge transfer activities: An efficiency analysis of Spanish universities

    Article • Journal of Business Research, October 2013, Elsevier

    Dr Jasmina Berbegal-Mirabent, FRANCESC SOLE

  148. 5q− syndrome and multiple myeloma diagnosed simultaneously and successful treated with lenalidomide

    Article • Leukemia Research, October 2013, Elsevier

    FRANCESC SOLE

  149. Acquisition of cytogenetic abnormalities in patients with IPSS defined lower‐risk myelodysplastic syndrome is associated with poor prognosis and transformation to acute myelogenous leukemia

    Article • American Journal of Hematology, July 2013, Wiley

    FRANCESC SOLE

  150. Biallelic losses of 13q do not confer a poorer outcome in chronic lymphocytic leukaemia: analysis of 627 patients with isolated 13q deletion

    Article • British Journal of Haematology, July 2013, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  151. Roles‐purpose‐and‐culture misalignments: a setback to bottom‐up SME clusters

    Article • Journal of Knowledge Management, July 2013, Emerald

    FRANCESC SOLE

  152. CD133 expression in circulating tumor cells from breast cancer patients: Potential role in resistance to chemotherapy

    Article • International Journal of Cancer, July 2013, Wiley

    FRANCESC SOLE

  153. Characterization and prognostic implication of 17 chromosome abnormalities in myelodysplastic syndrome

    Article • Leukemia Research, July 2013, Elsevier

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  154. Corrigendum to “Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): A population-based study, 1993–2007” [Leukemia Res. 36 (2012) 1262–1266]

    Article • Leukemia Research, July 2013, Elsevier

    FRANCESC SOLE

  155. Remisión espontánea de una aplasia de médula ósea asociada a una trisomía del cromosoma 8, con posterior evolución a leucemia monoblástica aguda y reaparición de la alteración clonal

    Article • Medicina Clínica, July 2013, Elsevier

    FRANCESC SOLE

  156. Monosomal karyotype in MDS: explaining the poor prognosis?

    Article • Leukemia, June 2013, Nature

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  157. Reciprocal translocations in myelodysplastic syndromes and chronic myelomonocytic leukemias: Review of 5,654 patients with an evaluable karyotype

    Article • Genes Chromosomes and Cancer, May 2013, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  158. P-068 Trisomy 8 in de novo MDS, constitutional or not constitutional?

    Article • Leukemia Research, May 2013, Elsevier

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  159. P-069 Contribution of SNP-arrays and mutational studies to diagnosis and prognosis of CMML with low-risk cytogenetic features or no metaphases

    Article • Leukemia Research, May 2013, Elsevier

    FRANCESC SOLE

  160. P-017 Genetic alterations of the epigenetic pathways on MDS patients with a 5q deletion drive specific methylation signatures

    Article • Leukemia Research, May 2013, Elsevier

    FRANCESC SOLE

  161. P-113 Revised International Prognostic Scoring System (IPSS-R) for primary treated myelodysplastic syndromes (MDS) patients: A report from the IWG-PM

    Article • Leukemia Research, May 2013, Elsevier

    FRANCESC SOLE

  162. Response to lenalidomide in myelodysplastic syndromes with del(5q): influence of cytogenetics and mutations

    Article • British Journal of Haematology, April 2013, Wiley

    FRANCESC SOLE

  163. Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does −7/7q− detection by FISH have prognostic value?

    Article • Leukemia Research, April 2013, Elsevier

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  164. Complex, Not Monosomal, Karyotype Is the Cytogenetic Marker of Poorest Prognosis in Patients With Primary Myelodysplastic Syndrome

    Article • Journal of Clinical Oncology, March 2013, American Society of Clinical Oncology (ASCO)

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  165. Identification of Temporal and Region-Specific Myocardial Gene Expression Patterns in Response to Infarction in Swine

    Article • PLoS ONE, January 2013, PLOS

    FRANCESC SOLE

  166. Study of Regulatory T-Cells in Patients with Gastric Malt Lymphoma: Influence on Treatment Response and Outcome

    Article • PLoS ONE, December 2012, PLOS

    FRANCESC SOLE

  167. Association of MDM2 Gene Polymorphisms SNP285 and 309 with Myelodysplastic Syndromes (MDS) Susceptibility and Outcome.

    Article • Blood, November 2012, American Society of Hematology

    FRANCESC SOLE

  168. Age, Performance Status and Plasma Interleukin-10 Levels At Diagnosis: A Triad for Improving Survival Prediction of Patients with Myelodysplastic Syndromes Already Stratified by IPSS-R. Spanish MDS Group (GESMD)

    Article • Blood, November 2012, American Society of Hematology

    FRANCESC SOLE

  169. Feasibility of the AMLprofiler™ (Skyline array) in Patient Risk-Stratification in a Multicenter Trial. Comparison with the Standard Approach

    Article • Blood, November 2012, American Society of Hematology

    FRANCESC SOLE

  170. Mutational Status of Splenic Marginal Zone Lymphoma Revealed by Whole Exome Sequencing.

    Article • Blood, November 2012, American Society of Hematology

    FRANCESC SOLE

  171. Genomic arrays in chronic lymphocytic leukemia routine clinical practice: are we ready to substitute conventional cytogenetics and fluorescencein situhybridization techniques?

    Article • Leukemia & Lymphoma, October 2012, Taylor & Francis

    FRANCESC SOLE

  172. C0149 Long-term treatment of venous thromboembolism, with moderate-intensity vitamin-k antagonists (VKA) (INR range between 1.8 - 2.5), improve patient comfort and decreases treatment costs, without increasing adverse effects: A matched paired study

    Article • Thrombosis Research, October 2012, Elsevier

    FRANCESC SOLE

  173. Incidence and survival of chronic myelomonocytic leukemia in Girona (Spain): A population-based study, 1993–2007

    Article • Leukemia Research, October 2012, Elsevier

    FRANCESC SOLE

  174. Revised International Prognostic Scoring System for Myelodysplastic Syndromes

    Article • Blood, September 2012, American Society of Hematology

    FRANCESC SOLE

  175. Prognostic value of trisomy 8 as a single anomaly and the influence of additional cytogenetic aberrations in primary myelodysplastic syndromes

    Article • British Journal of Haematology, September 2012, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  176. Applying a systems thinking framework to assess knowledge assets dynamics for business performance improvement

    Article • Expert Systems with Applications, July 2012, Elsevier

    Dr Daniela Carlucci, FRANCESC SOLE

  177. Will a peripheral blood (PB) sample yield the same diagnostic and prognostic cytogenetic data as the concomitant bone marrow (BM) in myelodysplasia?

    Article • Leukemia Research, July 2012, Elsevier

    FRANCESC SOLE

  178. Biomarkers characterization of circulating tumour cells in breast cancer patients

    Article • May 2012, Springer Science + Business Media

    FRANCESC SOLE

  179. Are ER+PR+ and ER+PR− breast tumors genetically different? A CGH array study

    Article • Cancer Genetics, April 2012, Elsevier

    FRANCESC SOLE

  180. New Comprehensive Cytogenetic Scoring System for Primary Myelodysplastic Syndromes (MDS) and Oligoblastic Acute Myeloid Leukemia After MDS Derived From an International Database Merge

    Article • Journal of Clinical Oncology, March 2012, American Society of Clinical Oncology (ASCO)

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  181. Update on developments in the diagnosis and prognostic evaluation of patients with myelodysplastic syndromes (MDS): Consensus statements and report from an expert workshop

    Article • Leukemia Research, March 2012, Elsevier

    FRANCESC SOLE

  182. ALK status in a primary lung tumour and metachronous metastases

    Article • Histopathology, January 2012, Wiley

    FRANCESC SOLE

  183. Molecular Biology of Myelodysplastic Syndromes

    Article • January 2012, Springer Science + Business Media

    FRANCESC SOLE

  184. Amplification of the G allele at SNP rs6983267 in 8q24 amplicons in myeloid malignancies as cause of the lack of MYC overexpression?

    Article • Blood Cells Molecules and Diseases, December 2011, Elsevier

    FRANCESC SOLE

  185. Prognostic Impact of Monosomal Karyotype in Patients with Myelodysplastic Syndrome and Abnormal Karyotype. A Report From the Spanish Group of MDS (GESMD)

    Article • Blood, November 2011, American Society of Hematology

    FRANCESC SOLE

  186. Circulating cancer cells in division in an early breast cancer patient

    Article • Annals of Oncology, September 2011, Elsevier

    FRANCESC SOLE

  187. Deletion of TET2 gene in an acute myeloid leukemia case with a t(4;15)(q24;q26) characterized by glass needle based chromosome microdissection and oligonucleotide array

    Article • Leukemia Research, September 2011, Elsevier

    FRANCESC SOLE

  188. Increased MLL gene rearrangements in amniocytes from fetuses of mothers who smoke

    Article • Leukemia Research, August 2011, Elsevier

    FRANCESC SOLE

  189. Absence of TCR loci chromosomal translocations in cutaneous T-cell lymphomas

    Article • Cancer Genetics, July 2011, Elsevier

    FRANCESC SOLE

  190. De la citogenética convencional al análisis por micromatrices. Cincuenta años del cromosoma Filadelfia

    Article • Medicina Clínica, July 2011, Elsevier

    FRANCESC SOLE

  191. Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome

    Article • Cancer, June 2011, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  192. A multicolor fluorescence in situ hybridization assay: A monitoring tool in the surveillance of patients with a history of non-muscle-invasive urothelial cell carcinoma

    Article • Cancer Cytopathology, June 2011, Wiley

    FRANCESC SOLE

  193. Clinical impact of the clone size in MDS cases with monosomy 7 or 7q deletion, trisomy 8, 20q deletion and loss of Y chromosome

    Article • Leukemia Research, June 2011, Elsevier

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  194. Linfocitosis B policlonal persistente: estudio de 35 casos

    Article • Medicina Clínica, May 2011, Elsevier

    FRANCESC SOLE

  195. Molecular diagnosis of dermatofibrosarcoma protuberans: A comparison between reverse transcriptase-polymerase chain reaction and fluorescence in situ hybridization methodologies

    Article • Genes Chromosomes and Cancer, April 2011, Wiley

    FRANCESC SOLE

  196. Absence of mutations of the histone methyltransferase gene EZH2 in splenic b-cell marginal zone lymphoma

    Article • Leukemia Research, March 2011, Elsevier

    FRANCESC SOLE

  197. Cryptic IGH/BCL2 rearrangements with variant FISH patterns in follicular lymphoma

    Article • Leukemia Research, February 2011, Elsevier

    FRANCESC SOLE

  198. Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays

    Article • Human Pathology, February 2011, Elsevier

    FRANCESC SOLE

  199. Which services support research activities at universities?

    Article • Service Industries Journal, January 2011, Taylor & Francis

    Dr Jasmina Berbegal-Mirabent, FRANCESC SOLE

  200. Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer

    Article • Journal of Thoracic Oncology, January 2011, Elsevier

    FRANCESC SOLE

  201. Primary Cutaneous CD30+ Anaplastic Large-Cell Lymphomas Show a Heterogeneous Genomic Profile: An Oligonucleotide ArrayCGH Approach

    Article • Journal of Investigative Dermatology, January 2011, Elsevier

    FRANCESC SOLE

  202. Cytogenetic risk stratification in chronic myelomonocytic leukemia

    Article • Haematologica, November 2010, Ferrata Storti Foundation (Haematologica)

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  203. Prognostic Impact of Monosomy 7 as a Single Anomaly In Primary MDS – Reclassification From Poor to Intermediate Prognosis

    Article • Blood, November 2010, American Society of Hematology

    FRANCESC SOLE

  204. Unrelated Clones In Myelodysplastic Syndromes and Acute Myeloid Leukemia - Characterization and Prognostic Relevance

    Article • Blood, November 2010, American Society of Hematology

    FRANCESC SOLE

  205. Kinetics of Regulatory T-Cells Are Highly Influenced by Treatment In Patients with Gastric MALT Lymphoma

    Article • Blood, November 2010, American Society of Hematology

    FRANCESC SOLE

  206. Loss of the Y Chromosome in MDS - Age-Related Phenomenon or Clonal Abnormality?

    Article • Blood, November 2010, American Society of Hematology

    FRANCESC SOLE

  207. Will a Peripheral Blood (PB) Sample Yield the Same Diagnostic and Prognostic Cytogenetic Data as the Concomitant Bone Marrow (BM) In Myelodysplasia? An International Study Comparing Cytogenetics and Interphase FISH Using Parallel PB and BM Samples

    Article • Blood, November 2010, American Society of Hematology

    FRANCESC SOLE

  208. Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q

    Article • Leukemia, September 2010, Nature

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  209. Does monosomy 5 really exist in myelodysplastic syndromes and acute myeloid leukemia?

    Article • Leukemia Research, September 2010, Elsevier

    FRANCESC SOLE

  210. CKS1B amplification is a frequent event in cutaneous squamous cell carcinoma with aggressive clinical behaviour

    Article • Genes Chromosomes and Cancer, August 2010, Wiley

    FRANCESC SOLE

  211. Multiple genetic copy number alterations in oral squamous cell carcinoma: study of MYC , TP53 , CCDN1, EGFR and ERBB2 status in primary and metastatic tumours

    Article • British Journal of Dermatology, July 2010, Oxford University Press (OUP)

    FRANCESC SOLE

  212. TET2 gene is not deleted in chronic myelomonocytic leukemia: a FISH retrospective study

    Article • Haematologica, June 2010, Ferrata Storti Foundation (Haematologica)

    FRANCESC SOLE

  213. ALK chromosomal alterations in colon cancer patients.

    Article • Journal of Clinical Oncology, May 2010, American Society of Clinical Oncology (ASCO)

    FRANCESC SOLE

  214. Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group

    Article • Blood, May 2010, American Society of Hematology

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  215. The capital gap for small technology companies: public venture capital to the rescue?

    Article • Small Business Economics, April 2010, Springer Science + Business Media

    FRANCESC SOLE

  216. Oligonucleotide Array-CGH Identifies Genomic Subgroups and Prognostic Markers for Tumor Stage Mycosis Fungoides

    Article • Journal of Investigative Dermatology, April 2010, Elsevier

    FRANCESC SOLE

  217. Loss of poly(ADP-ribose) polymerase-2 leads to rapid development of spontaneous T-cell lymphomas in p53-deficient mice

    Article • Oncogene, February 2010, Springer Science + Business Media

    FRANCESC SOLE

  218. Genomic and Gene Expression Profiling Defines Indolent Forms of Mantle Cell Lymphoma

    Article • Cancer Research, February 2010, American Association for Cancer Research (AACR)

    FRANCESC SOLE

  219. Epidermal growth factor receptor gene numerical aberrations are frequent events in actinic keratoses and invasive cutaneous squamous cell carcinomas

    Article • Experimental Dermatology, February 2010, Wiley

    FRANCESC SOLE

  220. Incidence and prognostic impact of secondary cytogenetic aberrations in a series of 145 patients with mantle cell lymphoma

    Article • Genes Chromosomes and Cancer, January 2010, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  221. Cytogenetic Risk Features in MDS-Update and Present State.

    Article • Blood, November 2009, American Society of Hematology

    FRANCESC SOLE

  222. Prognostic Value of Monosomal Karyotype in Patients with Primary Acute Myeloid Leukemia On Behalf of Spanish CETLAM Group.

    Article • Blood, November 2009, American Society of Hematology

    FRANCESC SOLE

  223. MYCgene numerical aberrations in actinic keratosis and cutaneous squamous cell carcinoma

    Article • British Journal of Dermatology, November 2009, Oxford University Press (OUP)

    FRANCESC SOLE

  224. SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1-negative subtype

    Article • Haematologica, October 2009, Ferrata Storti Foundation (Haematologica)

    FRANCESC SOLE

  225. 3q26 (hTERC) gain studied by fluorescence in situ hybridization as a persistence-progression indicator in low-grade squamous intraepithelial lesion cases

    Article • Human Pathology, October 2009, Elsevier

    FRANCESC SOLE

  226. MicroRNA Expression, Chromosomal Alterations, and Immunoglobulin Variable Heavy Chain Hypermutations in Mantle Cell Lymphomas

    Article • Cancer Research, August 2009, American Association for Cancer Research (AACR)

    FRANCESC SOLE

  227. Cytogenetic characterization of NCI-H69 and NCI-H69AR small cell lung cancer cell lines by spectral karyotyping

    Article • Cancer Genetics and Cytogenetics, June 2009, Elsevier

    FRANCESC SOLE

  228. P029 Prognostic relevance of specific chromosomal abnormalities in chronic myelomonocytic leukemia

    Article • Leukemia Research, May 2009, Elsevier

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  229. C005 Prognostic impact of the proportion of aberrant metaphases in patients with a primary myelodysplastic syndrome

    Article • Leukemia Research, May 2009, Elsevier

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  230. P030 Prognostic impact on survival of an unsuccessful conventional cytogenetic study in patients with myelodysplastic syndromes (MDS)

    Article • Leukemia Research, May 2009, Elsevier

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  231. 12 Updated cytogenetic risk features in MDS – present state

    Article • Leukemia Research, May 2009, Elsevier

    FRANCESC SOLE

  232. Spiculated red cells in erythroleukemia

    Article • European Journal Of Haematology, April 2009, Wiley

    FRANCESC SOLE

  233. FISH and immunohistochemical status of the hepatocyte growth factor receptor (c-Met) in 184 invasive breast tumors

    Article • April 2009, Springer Science + Business Media

    FRANCESC SOLE

  234. HPV Determination in the Control After LEEP Due to CIN II-III: Prospective Study and Predictive Model

    Article • International Journal of Gynecological Pathology, March 2009, Wolters Kluwer Health

    FRANCESC SOLE

  235. Some remarks on a current study involving preservice elementary teachers and some basic astronomical phenomena

    Article • Proceedings of the International Astronomical Union, January 2009, Cambridge University Press

    FRANCESC SOLE

  236. Multiple recurrent chromosomal breakpoints in mantle cell lymphoma revealed by a combination of molecular cytogenetic techniques

    Article • Genes Chromosomes and Cancer, December 2008, Wiley

    FRANCESC SOLE

  237. New Prognostic Data on Rare Cytogenetic Abnormalities in MDS: A Collaborative Study of the International Working Group on MDS Cytogenetics

    Article • Blood, November 2008, American Society of Hematology

    FRANCESC SOLE

  238. Blast cells with nuclear extrusions in the form of micronuclei are associated with MYC amplification in acute myeloid leukemia

    Article • Cancer Genetics and Cytogenetics, August 2008, Elsevier

    FRANCESC SOLE

  239. Gene expression profiling distinguishes JAK2V617F-negative from JAK2V617F-positive patients in essential thrombocythemia

    Article • Leukemia, May 2008, Springer Science + Business Media

    FRANCESC SOLE

  240. New chromosomal alterations in a series of 23 splenic marginal zone lymphoma patients revealed by Spectral Karyotyping (SKY)

    Article • Leukemia Research, May 2008, Elsevier

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  241. FISH is better than BIOMED-2 PCR to detect IgH/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections

    Article • Leukemia Research, May 2008, Elsevier

    FRANCESC SOLE

  242. Estudio de las lesiones citogenéticas en el carcinoma escamoso cutáneo mediante la técnica de arrays de hibridación genómica comparada

    Article • Actas Dermo-Sifiliográficas, April 2008, Elsevier

    FRANCESC SOLE

  243. Complex chromosome 8;21 translocation with associated hyperdiploidy in acute myeloid leukemia (FAB-M2)

    Article • Pediatric Blood & Cancer, March 2008, Wiley

    FRANCESC SOLE

  244. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-

    Article • Haematologica, January 2008, Ferrata Storti Foundation (Haematologica)

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  245. Gene expression analysis provides a potential rationale for revising the histological grading of follicular lymphomas

    Article • Haematologica, January 2008, Ferrata Storti Foundation (Haematologica)

    FRANCESC SOLE

  246. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria

    Article • Leukemia, December 2007, Springer Science + Business Media

    FRANCESC SOLE

  247. Gain of multiple copies of the CBFB gene: a new genetic aberration in a case of granulocytic sarcoma

    Article • Cancer Genetics and Cytogenetics, November 2007, Elsevier

    FRANCESC SOLE

  248. Could ATRA/Idarubicin treatment of acute promyelocytic leukemia induce the appearance of new clonal cytogenetic abnormalities in patients in complete remission?

    Article • Leukemia Research, September 2007, Elsevier

    FRANCESC SOLE

  249. A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation

    Article • Leukemia, May 2007, Springer Science + Business Media

    FRANCESC SOLE

  250. A higher JAK2 V617F-mutated clone is observed in platelets than in granulocytes from essential thrombocythemia patients, but not in patients with polycythemia vera and primary myelofibrosis

    Article • Leukemia, March 2007, Springer Science + Business Media

    FRANCESC SOLE

  251. Trisomy 8 as the sole chromosomal aberration in acute myeloid leukemia and myelodysplastic syndromes

    Article • Pathologie Biologie, February 2007, Elsevier

    FRANCESC SOLE

  252. Small supernumerary marker chromosome causing partial trisomy 6p in a child with craniosynostosis

    Article • American Journal of Medical Genetics Part A, January 2007, Wiley

    FRANCESC SOLE

  253. Does Polysomy of Chromosome 17 Have a Role in ERBB2 and Topoisomerase IIα Expression?

    Article • Tumor Biology, January 2007, Springer Science + Business Media

    FRANCESC SOLE

  254. Duplication dup(1)(q41q44) defined by fluorescence in situ hybridization: delineation of the ‘trisomy 1q42→qter syndrome’

    Article • Cytogenetic and Genome Research, January 2007, Karger Publishers

    FRANCESC SOLE

  255. Primitive neuroectodermal tumor of the central nervous system with glial differentiation: a FISH study of an adult case

    Article • Clinical Neuropathology, January 2007, Dustri-Verlgag Dr. Karl Feistle

    FRANCESC SOLE

  256. Detection of the JAK2 V617F Mutation by Real Time PCR in Granulocytes and Platelets of ET Patients.

    Article • Blood, November 2006, American Society of Hematology

    FRANCESC SOLE

  257. Elderly Patients with De Novo Acute Myeloid Leukemia (AML): Prognostic Factors in 132 Cases.

    Article • Blood, November 2006, American Society of Hematology

    FRANCESC SOLE

  258. Gastrointestinal Involvement in Mantle Cell Lymphoma: A Prospective Clinic, Endoscopic, and Pathologic Study

    Article • The American Journal of Surgical Pathology, October 2006, Wolters Kluwer Health

    FRANCESC SOLE

  259. JAK2 V617F mutation analysis in different myeloid lineages (granulocytes, platelets, CFU-MK, BFU-E and CFU-GM) in essential thrombocythemia patients

    Article • Leukemia, August 2006, Springer Science + Business Media

    FRANCESC SOLE

  260. Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma

    Article • Human Pathology, July 2006, Elsevier

    FRANCESC SOLE

  261. Detection of abnormalities of PRV-1, TPO, and c-MPL genes detected by fluorescence in situ hybridization in essential thrombocythemia

    Article • Cancer Genetics and Cytogenetics, May 2006, Elsevier

    FRANCESC SOLE

  262. The MYC oncogene in breast cancer progression: from benign epithelium to invasive carcinoma

    Article • Cancer Genetics and Cytogenetics, March 2006, Elsevier

    FRANCESC SOLE

  263. JAK2 V617F mutation, PRV-1 overexpression and endogenous erythroid colony formation show different coexpression patterns among Ph-negative chronic myeloproliferative disorders

    Article • Leukemia, February 2006, Springer Science + Business Media

    FRANCESC SOLE

  264. MYC-containing double minutes in hematologic malignancies: evidence in favor of the episome model and exclusion of MYC as the target gene

    Article • Human Molecular Genetics, February 2006, Oxford University Press (OUP)

    FRANCESC SOLE

  265. Study of chromosomal abnormalities in 11 cases of cervical dysplasia using comparative genomic hybridization on cotton-lint cervical samples

    Article • Cancer Genetics and Cytogenetics, January 2006, Elsevier

    FRANCESC SOLE

  266. Comparative genomic hybridization analysis of cutaneous large B-cell lymphomas

    Article • Experimental Dermatology, December 2005, Wiley

    FRANCESC SOLE

  267. Identification of Male Cardiomyocytes of Extracardiac Origin in the Hearts of Women with Male Progeny: Male Fetal Cell Microchimerism of the Heart

    Article • The Journal of Heart and Lung Transplantation, December 2005, Elsevier

    FRANCESC SOLE

  268. Insertion (8;11) in a renal oncocytoma with multifocal transformation to chromophobe renal cell carcinoma

    Article • Cancer Genetics and Cytogenetics, December 2005, Elsevier

    FRANCESC SOLE

  269. Characterization of New Aberrations in 25 Splenic Marginal Zone B-Cell Lymphomas (SMZBCL) Using Spectral Karyotyping Technique (SKY).

    Article • Blood, November 2005, American Society of Hematology

    FRANCESC SOLE

  270. Gastrointestinal Involvement in Mantle Cell Lymphoma (MCL). A Prospective Clinical, Endoscopical, Pathological and Molecular Study.

    Article • Blood, November 2005, American Society of Hematology

    FRANCESC SOLE

  271. Clonal proliferation of cyclin D1–positive mantle lymphocytes in an asymptomatic patient: an early-stage event in the development or an indolent form of a mantle cell lymphoma?

    Article • Human Pathology, November 2005, Elsevier

    FRANCESC SOLE

  272. Absence of CHEK2 mutations in Spanish families with hereditary breast cancer

    Article • Cancer Genetics and Cytogenetics, August 2005, Elsevier

    FRANCESC SOLE

  273. CD5 negative and CD5 positive splenic marginal B-cell lymphomas have differential cytogenetic patterns

    Article • Leukemia Research, August 2005, Elsevier

    FRANCESC SOLE

  274. Correlation between histologic findings and cytogenetic abnormalities in bladder carcinoma: A FISH study

    Article • Urology, May 2005, Elsevier

    FRANCESC SOLE

  275. Polysomy of chromosome 17 in breast cancer tumors showing an overexpression of ERBB2: a study of 175 cases using fluorescence in situhybridization and immunohistochemistry

    Article • January 2005, Springer Science + Business Media

    FRANCESC SOLE

  276. Characterization of HER1 (c-erbB1) Status in Locally Advanced Breast Cancer Using Fluorescence in situ Hybridization and Immunohistochemistry

    Article • Tumor Biology, January 2005, Springer Science + Business Media

    FRANCESC SOLE

  277. Collaborative Network Space: Infrastructure and Learning Application

    Article • January 2005, Institute of Electrical & Electronics Engineers (IEEE)

    FRANCESC SOLE

  278. Cytogenetic and FISH Study of 92 Patients with Splenic Marginal Zone B-Cell Lymphoma (SMZBCL).

    Article • Blood, November 2004, American Society of Hematology

    FRANCESC SOLE

  279. Lymphomatoid Papulosis Associated with Mycosis Fungoides: Clinicopathological and Molecular Studies of 12 Cases

    Article • Acta Dermato Venereologica, November 2004, Acta Dermato-Venereologica

    FRANCESC SOLE

  280. Activation of mitochondrial apoptotic pathway in mantle cell lymphoma: high sensitivity to mitoxantrone in cases with functional DNA-damage response genes

    Article • Oncogene, October 2004, Springer Science + Business Media

    FRANCESC SOLE

  281. Intratumoral heterogeneity of HER2/neu and topoisomerase IIα in breast cancer: a case with clonal monosomy 17

    Article • Cancer Genetics and Cytogenetics, October 2004, Elsevier

    FRANCESC SOLE

  282. Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia

    Article • Cancer Genetics and Cytogenetics, August 2004, Elsevier

    FRANCESC SOLE

  283. Is fluorescence in situ hybridization a useful method in diagnosis of polycythemia vera patients?

    Article • Cancer Genetics and Cytogenetics, June 2004, Elsevier

    FRANCESC SOLE

  284. Heterogeneity of structural abnormalities in the 7q31.3∼q34 region in myeloid malignancies

    Article • Cancer Genetics and Cytogenetics, April 2004, Elsevier

    FRANCESC SOLE

  285. Type IMOZ/CBP (MYST3/CREBBP)is the most common chimeric transcript in acute myeloid leukemia with t(8;16)(p11;p13) translocation

    Article • Genes Chromosomes and Cancer, March 2004, Wiley

    FRANCESC SOLE

  286. Endogenous erythroid and megakaryocytic circulating progenitors, HUMARA clonality assay, and PRV-1 expression are useful tools for diagnosis of polycythemia vera and essential thrombocythemia

    Article • Blood, March 2004, American Society of Hematology

    FRANCESC SOLE

  287. Cytogenetic and fluorescence in situ hybridization studies in 60 patients with multiple myeloma and plasma cell leukemia

    Article • Cancer Genetics and Cytogenetics, January 2004, Elsevier

    FRANCESC SOLE

  288. Comparative Analysis of TCR-γ Gene Rearrangements by Genescan and Polyacrylamide Gel-electrophoresis in Cutaneous T-cell Lymphoma

    Article • Acta Dermato Venereologica, December 2003, Acta Dermato-Venereologica

    FRANCESC SOLE

  289. Two cases of tetrasomy 9p syndrome with tissue limited mosaicism

    Article • American Journal of Medical Genetics Part A, September 2003, Wiley

    FRANCESC SOLE

  290. Cytogenetic findings in familial B-cell chronic lymphocytic leukemia

    Article • Cancer Genetics and Cytogenetics, June 2003, Elsevier

    FRANCESC SOLE

  291. Genomic rearrangements involving rDNA and centromeric heterochromatin in vulvar epidermoid carcinoma cell line A-431

    Article • Cancer Genetics and Cytogenetics, May 2003, Elsevier

    FRANCESC SOLE

  292. Additional i(1)(q10) in a primitive neuroectodermal tumor type Merkel cell carcinoma as a primary cytogenetic change

    Article • Cancer Genetics and Cytogenetics, April 2003, Elsevier

    FRANCESC SOLE

  293. 3572 Fetal cell microchimerism in the heart of women with dilated cardiomyopathy

    Article • European Heart Journal, March 2003, Elsevier

    FRANCESC SOLE

  294. Chimeric BCR/ABL gene detected by fluorescence in situ hybridization in three new cases of Philadelphia chromosome-negative chronic myelocytic leukemia

    Article • Cancer Genetics and Cytogenetics, March 2003, Elsevier

    FRANCESC SOLE

  295. De novo erythroleukemia chromosome features include multiple rearrangements, with special involvement of chromosomes 11 and 19

    Article • Genes Chromosomes and Cancer, January 2003, Wiley

    FRANCESC SOLE

  296. RxFISH karyotype andMYCamplification in the HT-29 colon adenocarcinoma cell line

    Article • Genes Chromosomes and Cancer, January 2003, Wiley

    FRANCESC SOLE

  297. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations

    Article • Blood, January 2003, American Society of Hematology

    FRANCESC SOLE

  298. HLA-G positive trophoblastic cells in transcervical samples and their isolation and analysis by laser microdissection and QF-PCR

    Article • Prenatal Diagnosis, January 2003, Wiley

    FRANCESC SOLE

  299. Genomic Abnormalities Acquired in the Blastic Transformation of Splenic Marginal Zone B-cell Lymphoma

    Article • Leukemia & Lymphoma, January 2003, Taylor & Francis

    FRANCESC SOLE

  300. Medical Malpractice Liability in Spain: Cases, Trends and Developments

    Article • European Journal of Health Law, January 2003, Brill

    FRANCESC SOLE

  301. Analysis of T-Cell Receptor γ Gene Rearrangements by PCR-Genescan and PCR-Polyacrylamide Gel Electrophoresis in Early-Stage Mycosis fungoides/Large-Plaque Parapsoriasis

    Article • Dermatology, January 2003, Karger Publishers

    FRANCESC SOLE

  302. Host cell-derived cardiomyocytes in sex-mismatch cardiac allografts

    Article • Cardiovascular Research, December 2002, European Society of Cardiology

    FRANCESC SOLE

  303. Clinical Utility of a Multiprobe FISH Assay in Voided Urine Specimens for the Detection of Bladder Cancer and its Recurrences, Compared with Urinary Cytology

    Article • European Urology, December 2002, Elsevier

    FRANCESC SOLE

  304. Genetic characterization of the paraimmunoblastic variant of small lymphocytic lymphoma/chronic lymphocytic leukemia: A case report and review of the literature

    Article • Human Pathology, November 2002, Elsevier

    FRANCESC SOLE

  305. Genetic Imbalances in Progressed B-Cell Chronic Lymphocytic Leukemia and Transformed Large-Cell Lymphoma (Richter's Syndrome)

    Article • American Journal Of Pathology, September 2002, Elsevier

    FRANCESC SOLE

  306. Cultures of myeloid progenitor cells in pediatric essential thrombocythemia

    Article • Leukemia, August 2002, Springer Science + Business Media

    FRANCESC SOLE

  307. Report of 46,XX/46,XY/47,XXY/48,XXYY mosaicism in an adult phenotypic male

    Article • American Journal of Medical Genetics, May 2002, Wiley

    FRANCESC SOLE

  308. Monosomy 15 in chronic myelomonocytic leukemia

    Article • Cancer Genetics and Cytogenetics, April 2002, Elsevier

    FRANCESC SOLE

  309. Analysis of the IgVH somatic mutations in splenic marginal zone lymphoma defines a group of unmutated cases with frequent 7q deletion and adverse clinical course

    Article • Blood, February 2002, American Society of Hematology

    FRANCESC SOLE

  310. Pentasomy 21 with two isochromosomes 21 in a case of acute myeloid leukemia without maturation

    Article • Cancer Genetics and Cytogenetics, January 2002, Elsevier

    FRANCESC SOLE

  311. A new case of acute nonlymphocytic leukemia (French–American–British subtype M1) with double minutes and c-MYC amplification

    Article • Cancer Genetics and Cytogenetics, January 2002, Elsevier

    FRANCESC SOLE

  312. Contribution of cytogenetics and in situ hybridization to the study of monoclonal gammopathies of undetermined significance

    Article • Cancer Genetics and Cytogenetics, January 2002, Elsevier

    FRANCESC SOLE

  313. Translocation (5;17)(q13;q21) in a case with precursor T-lymphoblastic lymphoma/leukemia

    Article • Cancer Genetics and Cytogenetics, January 2002, Elsevier

    FRANCESC SOLE

  314. Loss of a novel tumor suppressor gene locus at chromosome 8p is associated with leukemic mantle cell lymphoma

    Article • Blood, December 2001, American Society of Hematology

    FRANCESC SOLE

  315. Cyclin D3 is a target gene of t(6;14)(p21.1;q32.3) of mature B-cell malignancies

    Article • Blood, November 2001, American Society of Hematology

    Prof. Emanuele Zucca, FRANCESC SOLE

  316. A female infant with a 46,XX/48,XY,+8,+10 karyotype in prenatal diagnosis: a ‘vanishing twin’ phenomenon?

    Article • Prenatal Diagnosis, October 2001, Wiley

    FRANCESC SOLE

  317. Progression to Large B-Cell Lymphoma in Splenic Marginal Zone Lymphoma

    Article • The American Journal of Surgical Pathology, October 2001, Wolters Kluwer Health

    FRANCESC SOLE

  318. Detection of translocations affecting the BCL6 locus in B cell non-Hodgkin’s lymphoma by interphase fluorescence in situ hybridization

    Article • Leukemia, September 2001, Nature

    Dr ALESSANDRO Gozzetti, FRANCESC SOLE

  319. Acute myeloid leukemia with 17p abnormality in untreated essential thrombocythemia

    Article • Leukemia, July 2001, Springer Science + Business Media

    FRANCESC SOLE

  320. New t(11;12)(q12;q11) characterized by RxFISH in a patient with T-cell large granular lymphocyte leukemia

    Article • Cancer Genetics and Cytogenetics, February 2001, Elsevier

    FRANCESC SOLE

  321. Cytogenetic and Fluorescence In Situ Hybridization Studies in Four Cases of Plasma Cell Leukemia

    Article • Cancer Genetics and Cytogenetics, September 2000, Elsevier

    FRANCESC SOLE

  322. Dicentric (17;18) in a Case of Atypical B-Cell Chronic Lymphocytic Leukemia

    Article • Cancer Genetics and Cytogenetics, September 2000, Elsevier

    FRANCESC SOLE

  323. Translocation t(6;14)(p12;q32): a novel cytogenetic abnormality in splenic lymphoma with villous lymphocytes

    Article • British Journal of Haematology, July 2000, Wiley

    FRANCESC SOLE

  324. Isochromosome +i(3)(q10) in a new case of persistent polyclonal B-cell lymphocytosis (PPBL)

    Article • European Journal Of Haematology, May 2000, Wiley

    FRANCESC SOLE

  325. Incidence, characterization and prognostic significance of chromosomal abnormalities in 640 patients with primary myelodysplastic syndromes

    Article • British Journal of Haematology, February 2000, Wiley

    MD PhD ELISA E LUÑO , FRANCESC SOLE

  326. A New Case of Turner Syndrome Associated with Multiple Myeloma

    Article • Cancer Genetics and Cytogenetics, February 2000, Elsevier

    FRANCESC SOLE

  327. Simultaneous occurrence of the 5q- syndrome and multiple myeloma

    Article • International Journal of Laboratory Hematology, February 2000, Wiley

    FRANCESC SOLE

  328. Translocation (11;14)(q13;q32) and Preferential Involvement of Chromosomes 1, 2, 9, 13, and 17 in Mantle Cell Lymphoma

    Article • Cancer Genetics and Cytogenetics, May 1999, Elsevier

    FRANCESC SOLE

  329. Cytogenetic Findings in Five Patients with Hairy Cell Leukemia

    Article • Cancer Genetics and Cytogenetics, April 1999, Elsevier

    FRANCESC SOLE

  330. Major vascular complications in essential thrombocythemia: a study of the predictive factors in a series of 148 patients

    Article • Leukemia, February 1999, Springer Science + Business Media

    FRANCESC SOLE

  331. Cytogenetic Abnormalities in Three Patients with B-Cell Prolymphocytic Leukemia

    Article • Cancer Genetics and Cytogenetics, May 1998, Elsevier

    FRANCESC SOLE

  332. Two New Cases of Near-Tetraploidy in Adult Acute Myeloid Leukemia

    Article • Cancer Genetics and Cytogenetics, April 1998, Elsevier

    FRANCESC SOLE

  333. Frequent involvement of chromosomes 1, 3, 7 and 8 in splenic marginal zone B‐cell lymphoma

    Article • British Journal of Haematology, August 1997, Wiley

    FRANCESC SOLE

  334. A new case of trisomy 21 in a patient with an acute nonlymphocytic leukemia (M5b)

    Article • Cancer Genetics and Cytogenetics, June 1997, Elsevier

    FRANCESC SOLE

  335. Coexistence of tetrasomy 8 and trisomy 8 in a case with myeloid metaplasia with myelofibrosis

    Article • Cancer Genetics and Cytogenetics, April 1997, Elsevier

    FRANCESC SOLE

  336. 116 Cytogenetic studies in 429 myelodysplastic syndromes:Prognostic value

    Article • Leukemia Research, April 1997, Elsevier

    FRANCESC SOLE

  337. 26 Cytoplasmic abnormalities of erythroblasts in a patient with refractory anaemia with ring sideroblasts

    Article • Leukemia Research, April 1997, Elsevier

    FRANCESC SOLE

  338. 129 Deletion sq- in a patient with a secondary myelodysplastic syndromes post multiple myeloma

    Article • Leukemia Research, April 1997, Elsevier

    FRANCESC SOLE

  339. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: Primary breakpoints and clinical correlations

    Article • Genes Chromosomes and Cancer, February 1997, Wiley

    FRANCESC SOLE

  340. Cytogenetic studies in seventy-six cases of B-chronic lymphoproliferative disorders

    Article • Cancer Genetics and Cytogenetics, February 1997, Elsevier

    FRANCESC SOLE

  341. Trisomy 12 is a rare cytogenetic finding in typical chronic lymphocytic leukemia

    Article • Leukemia Research, May 1996, Elsevier

    FRANCESC SOLE

  342. Cytogenetic abnormalities in 13 patients with multiple myeloma

    Article • Cancer Genetics and Cytogenetics, February 1996, Elsevier

    FRANCESC SOLE

  343. Mortality in Testicular Cancer: 10 Years’ Experience at a Single Centre

    Article • Urologia Internationalis, January 1996, Karger Publishers

    FRANCESC SOLE

  344. A new case of trisomy 5 as sole cytogenetic anomaly in acute myeloid leukemia

    Article • Cancer Genetics and Cytogenetics, October 1995, Elsevier

    FRANCESC SOLE

  345. Trisomy 13 in a patient with a myelodysplastic syndrome

    Article • Cancer Genetics and Cytogenetics, June 1995, Elsevier

    FRANCESC SOLE

  346. Refractory anemia with excess of blasts and isochromosome 12p in a patient with primary mediastinal germ-cell tumor

    Article • Cancer Genetics and Cytogenetics, October 1994, Elsevier

    FRANCESC SOLE

  347. Burkitt's type translocation in multiple myeloma

    Article • Leukemia Research, September 1994, Elsevier

    FRANCESC SOLE

  348. Chromosomal and in vitro culture studies in a case of primary plasma cell leukemia

    Article • Cancer Genetics and Cytogenetics, August 1994, Elsevier

    FRANCESC SOLE

  349. Congenital dyserythropoietic anemia type II: Morphological characterization of the erythroid colonies (BFU-E) from the bone marrow and peripheral blood of two patients

    Article • Annals of Hematology, August 1994, Springer Science + Business Media

    FRANCESC SOLE

  350. A new case of t(14;19) (q32;q13) in a patient with follicular lymphoma in leukemic phase

    Article • Cancer Genetics and Cytogenetics, July 1994, Elsevier

    FRANCESC SOLE

  351. Cytogenetic studies in five patients with Sézary syndrome

    Article • Cancer Genetics and Cytogenetics, July 1994, Elsevier

    FRANCESC SOLE

  352. Granular lymphocyte proliferative disorders: A multicenter study of 20 cases

    Article • Annals of Hematology, June 1994, Springer Science + Business Media

    FRANCESC SOLE

  353. Trisomy 4 in a patient with acute myelomonocytic leukemia (M4)

    Article • Cancer Genetics and Cytogenetics, October 1993, Elsevier

    FRANCESC SOLE

  354. A case of monosomy 20 in an adult acute lymphoblastic leukemia

    Article • Cancer Genetics and Cytogenetics, September 1993, Elsevier

    FRANCESC SOLE

  355. Chronic neutrophilic leukemia associated with monoclonal gammopathy of undetermined significance

    Article • Annals of Hematology, September 1993, Springer Science + Business Media

    FRANCESC SOLE

  356. Isochromosome 17q as a sole anomaly: A distinct myelodysplastic syndrome entity?

    Article • Leukemia Research, August 1993, Elsevier

    FRANCESC SOLE

  357. A new chromosomal anomaly associated with mature B-cell chronic lymphoproliferative disorders: del(7)(q32)

    Article • Cancer Genetics and Cytogenetics, February 1993, Elsevier

    FRANCESC SOLE

  358. Microwaves improve chromosome G-banding in fresh blood and bone marrow.

    Article • Journal of Clinical Pathology, December 1992, BMJ

    FRANCESC SOLE

  359. Cytogenetic studies in 112 cases of untreated myelodysplastic syndromes

    Article • Cancer Genetics and Cytogenetics, November 1992, Elsevier

    FRANCESC SOLE

  360. t(6;9)(p22;q34) associated with acute myeloblastic leukemia (M1)

    Article • Cancer Genetics and Cytogenetics, October 1992, Elsevier

    FRANCESC SOLE

  361. Cytogenetic studies in acute nonlymphocytic leukemia

    Article • Cancer Genetics and Cytogenetics, June 1992, Elsevier

    FRANCESC SOLE

  362. New chromosomal abnormality

    Article • Cancer Genetics and Cytogenetics, June 1992, Elsevier

    FRANCESC SOLE

  363. t(3;14)(q26;q11) associated with megakaryoblastic transformation of chronic myeloid leukemia

    Article • Cancer Genetics and Cytogenetics, August 1991, Elsevier

    FRANCESC SOLE

  364. Isochromosome 14q in myeloid dysplastic disorder

    Article • Cancer Genetics and Cytogenetics, July 1991, Elsevier

    FRANCESC SOLE

  365. G-banding improvement for the MAC method

    Article • Cancer Genetics and Cytogenetics, January 1991, Elsevier

    FRANCESC SOLE

  366. Acute lymphoblastic leukemia with t(4;11) in a patient previously exposed to a carcinogen

    Article • Cancer Genetics and Cytogenetics, October 1990, Elsevier

    FRANCESC SOLE

  367. Cytogenetic study of a patient with the Sézary syndrome

    Article • Cancer Genetics and Cytogenetics, February 1990, Elsevier

    FRANCESC SOLE

  368. Translocation (2;7)(p13;q36) in a case of acute nonlymphocytic leukemia evolving from a myelodysplastic syndrome

    Article • Cancer Genetics and Cytogenetics, October 1988, Elsevier

    FRANCESC SOLE